|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 药剂师处方改善社区居民血压的随机试验:Alberta改善高血压临床试验显示文摘高血压控制率高居不下。执业药师的临床作用不断扩大,其在改善社区高血压治疗方面可能有较大帮助。该研究旨在确定药剂师处方对社区居住患者血压控制的影响。方法:研究人员进行随机对照试验,通过Alberta省23个社区药店、医院或基层医疗小组,纳入血压高于目标血压的成年患者。 | 刘莉 叶鹏 Tsuyuki RT Houle SK Charrois TL Kolber MR Rosenthal MM Lewanczuk R Campbell NR Cooney D McAlister FA | 2015 | 中华高血压杂志2015，23，7： | 2 |
| 2 | Drug insight: vascular disrupting agents and angiogenesis-novel approaches for drug delivery显示文摘 | Cooney MM Van heeckeren W Bhakta S | 2006 | Nat Clin Pract Oncol2006，3，12： | 1 |
| 3 | Application of fast-tracksurgery principles to evaluate effects of atipamezole on recovery andanalgesia following ovariohysterectomy in cats anesthetized withdexmedetomidine-ketamine-hydromorphone 显示文摘 | Hasiuk MM Brown D Cooney C | 2015 | J Am Vet MedAssoc2015，246，6： | 1 |
| 4 | A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck显示文摘 | Tserng KY Makar V | 2005 | Cancer Chemother Pharmacol2005，55，3： | 1 |
| 5 | A medical oncologist's approach to immunotherapy for advanced renal tumors: is nephrectomy indicated?显示文摘 | Cooney MM Remick SC Vogelzang NJ | 2004 | Curr Urol Rep2004，5，1： | 1 |
| 6 | A phase 1 study of bevacizumab in combination with sunitinib in advanced solid tumors 显示文摘 | COONEY MM GARCIA J BRELL J | 2007 | J Clin Oncol2007，25，15： | 1 |
| 7 | Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes显示文摘 | Doolittle MM Cooney JJ Caldwell DE | 1996 | J Ind Microbiol1996，16，6： | 1 |
| 8 | A medical oncologist's ap-proach to immunotherapy foradvanced renal tumors : isne- phrectomy in-dicated? 显示文摘 | Cooney MM Remlck SC Vogelzang NJ | 2004 | Curr Urol Rep2004，5，1： | 1 |
| 9 | A Phase IB clinical and pharmaco-kinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck显示文摘 | Cooney MM Tserng KY Makar V | 2005 | Cancer Chemother Pharmacol2005，55，3： | 1 |
| 10 | Cardiovascular safety profilee of combretastatin A4 phosphate in a single-dose phase Ⅰ study in patients with advanced cancer显示文摘 | COONEY MM RADIVOYEVITCH T DOWLATI A | 2004 | Clin Cancer Res2004，10，11： | 1 |
| 11 | Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer显示文摘 | Cooney MM Radivoyevitch T Dowlati A | 2004 | Clin Cancer Res2004，10，： | 1 |
| 12 | Hypertension,proteinuria,and antagonism of vascular endothelial growth factor signaling:clinical toxicity,therapeutic target,or novel biomarker显示文摘 | van Heeckeren WJ Ortiz J Cooney MM | | 0，，21： | 1 |
| 13 | Phase I trial of pomalido- mide given for patients with advanced solid tumors显示文摘 | Cooney MM Nock C Bokar J | 2012 | Can Chem Pharmacol2012，70，5： | 1 |
| 14 | Promising systemiC therapy for renal cell carcinoma显示文摘 | COONEY MM REMICK SC VOGELZANG NJ | 2005 | Curt Treat Options Oncol2005，6，5： | 1 |
| 15 | Phase I trial of pomalido- mide given for patients with advanced solid tumors 显示文摘 | Cooney MM Nock C Bokar J | 2012 | Cancer Chemother Pharmacol2012，70，5： | 1 |
| 16 | Hyperten- sion,proteinuria,and antagonism of vascular endothelial growth factor signaling: clinical toxicity,therapeutic tar- get, or novel biomarker? 显示文摘 | van Heeckeren WJ Ortiz J Cooney MM | 2007 | J Clin Oncol2007，25，21： | 1 |
| 17 | Lytie infection of escherichia coli biofihns by bacteriophage T4显示文摘 | Doolittle MM Cooney JJ Caldwell DE | 1995 | Can J Microbiol1995，1，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员